Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women
NCT00543790
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Leiomyomata (Fibroids)
Interventions
DRUG:
PRA-027
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer